Products
Several software products are designed by Epifocus LLC to assist with understanding, localization, prediction and control of crises of brain’s function through novel spatiotemporal analyses of brain’s electrical (EEG) and magnetic (MEG) waves, such solutions will assist with automated and accurate identification of the pathological brain region that initiates epileptic seizures (see References and related IP).
System and Method for Identifying a Focal Area of Abnormal Network Interactions in the Brain, filed on March 11, 2014; United States Patent No. 9,730,628 , awarded on August 15, 2017.
Biomarkers for Determining Susceptibility to SUDEP filed on July 21, 2015; United States Patent No. 10,327,661 awarded on June 25, 2019.
System and Method for Identifying a Focal Area of Functional Pathology in Anesthetized Subjects with Neurological Disorders, filed on Sept. 14, 2018; PCT/US 18/51103. PCT/US 2021/0045646 A1 awarded on February 18, 2021.
System and Method for Network Analysis of a Patient’s Neuro-Cardio-Respiratory System, September 3, 2019 (PCT/US19/49313)